百令胶囊联合厄贝沙坦治疗IgA肾病31例临床疗效观察

目的观察百令胶囊联合厄贝沙坦治疗IgA肾病的临床疗效。方法：66例IgA肾病患者随机分为百令联合厄贝沙坦组（治疗组）31例，厄贝沙坦组（对照组）35例，比较治疗前后Upro、SBP、DBP的差异。结果：Upro治疗后较治疗前显著减低，治疗组更显著（P〈0．05）；SBP、DBP治疗后较治疗前显著降低，下降幅度治疗组与对照组比较无统计学意义（P〉O．05）。结论：百令胶囊联合厄贝沙坦治疗IgA肾病具有协同作用，可以延缓IgA肾病的进展。

Objective To observe the clinical curative effec ts of Bailing Capsule Combined with irbesartan in the treatment of IgAnephropathy. Methods： 66 cases of IgA nephropathy were randomly divided into Bailing Capsule combined with irbesartan group （treatmentgroup） 31 cases, irbesartan group （control group） in 35 cases, compared with the treatment differences before and after Upro, SBP and DBP.Results： Upro after treatment was significantly lower than before treatment, the treatment group was more significant （P〈0.05）. After treatment,SBP and DBP were significantly lower than before treatment, and there was no significant reduction in the treatment group compared with thecontrol group （P〉0.05）.Conclusion： Bailing Capsule Combined with irbesartan in the treatment of IgA nephropathy has a synergistic effect, candelay the progress of IgA nephropathy.